Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 275

1.

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

Goos JA, Hiemstra AC, Coupé VM, Diosdado B, Kooijman W, Delis-Van Diemen PM, Karga C, Beliën JA, Menke-van der Houven van Oordt CW, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ; the DeCoDe PET group.

Br J Cancer. 2014 Jul 1. doi: 10.1038/bjc.2014.354. [Epub ahead of print]

PMID:
24983372
[PubMed - as supplied by publisher]
2.

Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.

Draht MX, Smits KM, Tournier B, Jooste V, Chapusot C, Carvalho B, Cleven AH, Derks S, Wouters KA, Belt EJ, Stockmann HB, Bril H, Weijenberg MP, van den Brandt PA, de Bruïne AP, Herman JG, Meijer GA, Piard F, Melotte V, van Engeland M.

Mol Oncol. 2014 May;8(3):679-88. doi: 10.1016/j.molonc.2014.01.011. Epub 2014 Feb 2.

PMID:
24560444
[PubMed - in process]
3.

Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent.

Mekenkamp LJ, Haan JC, Israeli D, van Essen HF, Dijkstra JR, van Cleef P, Punt CJ, Meijer GA, Nagtegaal ID, Ylstra B.

PLoS One. 2014 Feb 5;9(2):e86833. doi: 10.1371/journal.pone.0086833. eCollection 2014.

PMID:
24505270
[PubMed - in process]
Free PMC Article
4.

Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.

de Groen FL, Krijgsman O, Tijssen M, Vriend LE, Ylstra B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

Genes Chromosomes Cancer. 2014 Apr;53(4):339-48. doi: 10.1002/gcc.22144. Epub 2014 Jan 29.

PMID:
24478024
[PubMed - in process]
5.

Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.

de Wit M, Kant H, Piersma SR, Pham TV, Mongera S, van Berkel MP, Boven E, Pontén F, Meijer GA, Jimenez CR, Fijneman RJ.

J Proteomics. 2014 Mar 17;99:26-39. doi: 10.1016/j.jprot.2014.01.001. Epub 2014 Jan 10.

PMID:
24418523
[PubMed - in process]
6.

High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.

Labots M, Buffart TE, Haan JC, van Grieken NC, Tijssen M, van de Velde CJ, Grabsch HI, Ylstra B, Carvalho B, Fijneman RJ, Verheul HM, Meijer GA.

Cell Oncol (Dordr). 2014 Feb;37(1):41-52. doi: 10.1007/s13402-013-0162-4. Epub 2013 Dec 31.

PMID:
24379144
[PubMed - in process]
7.

Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.

Knol JC, de Wit M, Albrethsen J, Piersma SR, Pham TV, Mongera S, Carvalho B, Fijneman RJ, Meijer GA, Jiménez CR.

Biochim Biophys Acta. 2014 May;1844(5):1034-43. doi: 10.1016/j.bbapap.2013.12.006. Epub 2013 Dec 17.

PMID:
24361553
[PubMed - indexed for MEDLINE]
8.

Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.

Voorham QJ, Janssen J, Tijssen M, Snellenberg S, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken BJ, Mulder CJ, van Engeland M, Meijer GA, Steenbergen RD, Carvalho B.

BMC Cancer. 2013 Dec 19;13:603. doi: 10.1186/1471-2407-13-603.

PMID:
24350795
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited.

Snaebjornsson P, Coupe VM, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG.

Int J Cancer. 2014 Jul 15;135(2):467-78. doi: 10.1002/ijc.28676. Epub 2014 Jan 10.

PMID:
24347179
[PubMed - indexed for MEDLINE]
10.

Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.

Belt EJ, Stockmann HB, Delis-van Diemen PM, Bril H, Tijssen M, van Essen HF, Heymans MW, Beliën JA, Carvalho B, Cillessen SA, Meijer GA.

J Surg Oncol. 2014 Mar;109(3):255-65. doi: 10.1002/jso.23495. Epub 2013 Nov 19.

PMID:
24249458
[PubMed - indexed for MEDLINE]
11.

DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer.

van Boerdonk RA, Daniels JM, Snijders PJ, Grünberg K, Thunnissen E, van de Wiel MA, Ylstra B, Postmus PE, Meijer CJ, Meijer GA, Smit EF, Sutedja TG, Heideman DA.

Thorax. 2014 May;69(5):451-7. doi: 10.1136/thoraxjnl-2013-203821. Epub 2013 Nov 13.

PMID:
24227199
[PubMed - indexed for MEDLINE]
12.

Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA).

Greuter MJ, Xu XM, Lew JB, Dekker E, Kuipers EJ, Canfell K, Meijer GA, Coupé VM.

Risk Anal. 2014 May;34(5):889-910. doi: 10.1111/risa.12137. Epub 2013 Oct 31.

PMID:
24172539
[PubMed - in process]
13.

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.

Goos JA, Coupe VM, Diosdado B, Delis-Van Diemen PM, Karga C, Beliën JA, Carvalho B, van den Tol MP, Verheul HM, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJ; DeCoDe PET group.

Br J Cancer. 2013 Oct 29;109(9):2445-52. doi: 10.1038/bjc.2013.608. Epub 2013 Oct 8.

PMID:
24104968
[PubMed - indexed for MEDLINE]
14.

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.

Snoeren N, Emmink BL, Koerkamp MJ, van Hooff SR, Goos JA, van Houdt WJ, de Wit M, Prins AM, Piersma SR, Pham TV, Belt EJ, Bril H, Stockmann HB, Meijer GA, van Hillegersberg R, Holstege FC, Jimenez CR, Fijneman RJ, Kranenburg OW, Rinkes IH.

Br J Cancer. 2013 Sep 17;109(6):1636-47. doi: 10.1038/bjc.2013.489. Epub 2013 Sep 3.

PMID:
24002600
[PubMed - indexed for MEDLINE]
15.

The role of KCNQ1 in mouse and human gastrointestinal cancers.

Than BL, Goos JA, Sarver AL, O'Sullivan MG, Rod A, Starr TK, Fijneman RJ, Meijer GA, Zhao L, Zhang Y, Largaespada DA, Scott PM, Cormier RT.

Oncogene. 2013 Aug 26. doi: 10.1038/onc.2013.350. [Epub ahead of print]

PMID:
23975432
[PubMed - as supplied by publisher]
16.

EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.

Hubers AJ, Heideman DA, Yatabe Y, Wood MD, Tull J, Tarón M, Molina MA, Mayo C, Bertran-Alamillo J, Herder GJ, Koning R, Sie D, Ylstra B, Meijer GA, Snijders PJ, Witte BI, Postmus PE, Smit EF, Thunnissen E.

Lung Cancer. 2013 Oct;82(1):38-43. doi: 10.1016/j.lungcan.2013.07.011. Epub 2013 Aug 5.

PMID:
23927883
[PubMed - indexed for MEDLINE]
17.

The future of colorectal cancer: implications of screening.

Neerincx M, Buffart TE, Mulder CJ, Meijer GA, Verheul HM.

Gut. 2013 Oct;62(10):1387-9. doi: 10.1136/gutjnl-2013-305023. Epub 2013 Jun 8. No abstract available.

PMID:
23749605
[PubMed - indexed for MEDLINE]
18.

Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.

Gross S, van Wanrooij RL, Nijeboer P, Gelderman KA, Cillessen SA, Meijer GA, Mulder CJ, Bouma G, von Blomberg BM, Bontkes HJ.

Mediators Inflamm. 2013;2013:939047. doi: 10.1155/2013/939047. Epub 2013 Apr 15.

PMID:
23690672
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis.

Voorham QJ, Rondagh EJ, Knol DL, van Engeland M, Carvalho B, Meijer GA, Sanduleanu S.

Am J Gastroenterol. 2013 Jul;108(7):1042-56. doi: 10.1038/ajg.2013.126. Epub 2013 May 7. Review.

PMID:
23649184
[PubMed - indexed for MEDLINE]
20.

A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis.

Simons CC, Hughes LA, Smits KM, Khalid-de Bakker CA, de Bruïne AP, Carvalho B, Meijer GA, Schouten LJ, van den Brandt PA, Weijenberg MP, van Engeland M.

Ann Oncol. 2013 Aug;24(8):2048-56. doi: 10.1093/annonc/mdt076. Epub 2013 Mar 26.

PMID:
23532114
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk